← SynDRA
CELGOSIVIR
SynDRA canonical compound SYN0033405 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | MOGS |
| Mechanism of action | glucosidase inhibitor |
All known targets
Mechanisms of action (all sources)
- MGAM INHIBITOR
- Alpha glucosidase inhibitor
- GAA INHIBITOR
- SI INHIBITOR
- MGAM2 INHIBITOR
- glucosidase inhibitor
- MGAM MODULATOR
Cross-references
Synonyms
- BuCast
- MDL-28574
- B-CAST
- MBI-3253
- MDL 28,574
- MDL 28,574A
- MX-3253
- VIR-222
- Butanoic acid, (1S,6S,7S,8R,8aR)-octahydro-1,7,8-trihydroxy-6-indolizinyl ester
- [(1S,6S,7S,8R,8aR)-1,7,8-trihydroxy-1,2,3,5,6,7,8,8a-octahydroindolizin-6-yl] butanoate
- (1S,6S,7S,8R,8aR)-Octahydro-1,7,8-trihydroxy-6-indolizinyl butyrate;6-O-Butanoylcastanospermine
- 6-O-Butanoylcastanospermine
- MX 3253
- MDL 28574
- celgosivirum
- RefChem:124291
- DTXCID1075644
- MBI3253
- MX3253
- Celgosivir [INN]
- 6-O-Butyrylcastanospermine
- UNII-895VG117HN
- MBI 3253; MDL 28574; MX3253
- CELGOSIVIR [WHO-DD]
- SCHEMBL135812
- orb1710093
- AKOS030526324
- CS-5634
- FC45099
- T10755L
- NCGC00510887-02
- DA-62197
- HY-16134
- TS-07725
- NS00069214
- 6-O-butanoylcastanospermine
- 西戈斯韦
- C12H22ClNO5
Look up CELGOSIVIR in the interactive SynDRA portal →